and HBeAg(-) patients - World Journal of Gastroenterology
and HBeAg(-) patients - World Journal of Gastroenterology
and HBeAg(-) patients - World Journal of Gastroenterology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Ghimire P et al . Primary GI lymphoma<br />
pull enteroscopy which is capable <strong>of</strong> enabling biopsies<br />
as well as performing interventions, <strong>and</strong> limiting major<br />
surgical interventions. Small intestine lymphoma appears<br />
as a mass, polyp <strong>and</strong> ulcer on CE which cannot be<br />
distinguished from other lesions [51] . Radiologic findings<br />
<strong>of</strong> small intestinal lymphoma are not specific, thus posing<br />
a difficulty in distinguishing it from other benign <strong>and</strong><br />
malignant lesions. The common features <strong>of</strong> small intestine<br />
lymphoma seen in barium studies <strong>and</strong> CT include<br />
polypoid form, multiple nodules, infiltrative form, endoexoenteric<br />
form with excavation <strong>and</strong> fistulization, <strong>and</strong><br />
mesenteric invasive form with an extraluminal mass. The<br />
radiological findings usually do not correlate to its pathological<br />
subtypes. Certain features are, however, peculiarly<br />
noted. MCL, follicular lymphoma <strong>and</strong> MALT lymphoma<br />
rarely present with multiple polyps (multiple lymphomatous<br />
polyposis) [52] . Burkitt lymphoma usually presents as<br />
a bulky mass in the right lower quadrant. IPSID tends<br />
to affect proximally with a disseminated nodular pattern<br />
leading to mucosal fold thickening, irregularity <strong>and</strong> speculation.<br />
EATL, usually proximal or diffuse, shows nodules,<br />
ulcers or strictures [53] . PTCL preferentially involves the<br />
jejunum with an increased tendency to perforate [54] .<br />
Colorectal lymphoma<br />
Colorectal lymphoma constitutes 6%-12% <strong>of</strong> all gastrointestinal<br />
lymphomas. Most colorectal lymphomas are secondary<br />
involvement <strong>of</strong> the wide spread diseases. Primary<br />
colorectal lymphoma is very rare, constituting only 0.2%<br />
<strong>of</strong> all malignant tumors arising from the colorectal region<br />
with caecum, ascending colon <strong>and</strong> rectum more <strong>of</strong>ten affected<br />
[55] . The disease predominantly affects males in the<br />
fifth-seventh decade <strong>of</strong> life with abdominal pain, loss <strong>of</strong><br />
weight, palpable abdominal mass or lower gastrointestinal<br />
bleeding. Obstruction <strong>and</strong> perforation are relatively rare in<br />
<strong>patients</strong> with colorectal lymphoma [56] .<br />
Lymphoma <strong>of</strong> the colorectal region is mostly the B-cell<br />
lineage as other sites <strong>of</strong> the gastrointestinal tract. Primary<br />
colorectal lymphoma comprises low grade B-cell lymphoma<br />
arising from MALT, MCL <strong>and</strong> T-cell lymphoma<br />
besides large B cell lymphoma. The role <strong>of</strong> H. pylori in the<br />
pathogenesis <strong>of</strong> colorectal lymphoma has not been fully<br />
established [57] . Colorectal MALT-lymphoma is less common<br />
in colon <strong>and</strong> rectum than in small intestine. MCL in<br />
the colorectal region presents usually in the setting <strong>of</strong> diffuse<br />
systemic diseases. Peripheral T-cell lymphoma is rare<br />
in Western countries with an increasing frequency in many<br />
Asian countries, <strong>and</strong> is more aggressive in nature than<br />
other types with perforation as its common feature, <strong>and</strong><br />
its prognosis is poor [58] .<br />
Endoscopically, lymphoma appears to be fungating,<br />
ulcerative, infiltrative, ulcer<strong>of</strong>ungating, <strong>and</strong> ulceroinfiltrative<br />
types, with fungating <strong>and</strong> ulcer<strong>of</strong>ungating types being<br />
more common [59] . The radiologic appearances <strong>of</strong> colorectal<br />
lymphoma are variable <strong>and</strong> significantly overlapped<br />
with other benign <strong>and</strong> malignant condition <strong>of</strong> the colorectal<br />
region. The imaging findings during double-contrast<br />
barium enema can be divided into focal <strong>and</strong> diffuse lesions.<br />
The observed focal lesions include polypoid mass,<br />
WJG|www.wjgnet.com<br />
circumferential infiltration with smooth mucosal surface<br />
or extensive ulceration, cavitary mass, mucosal nodularity,<br />
<strong>and</strong> mucosal fold thickening. Diffuse lesions encompass<br />
diffuse ulcerative <strong>and</strong> nodular lesions. Peripheral T-cell<br />
lymphoma presents as a diffuse or focal segmental lesion<br />
with extensive mucosal ulceration similar to that observed<br />
in granulomatous conditions as Crohn’s disease or tuberculosis.<br />
MALT lymphoma is manifested as multiple mucosal<br />
nodularity [60,61] .<br />
TREATMENT<br />
The treatment strategy for gastrointestinal lymphoma is<br />
dependent on the age <strong>of</strong> <strong>patients</strong>, clinical scenario, histological<br />
subtype, extent <strong>and</strong> burden <strong>of</strong> the disease, <strong>and</strong> comorbidity,<br />
besides other factors. Surgery, chemotherapy,<br />
radiotherapy <strong>and</strong> radioimmunotherapy are the different<br />
modalities for its management <strong>and</strong> can be applied in different<br />
combinations. A detailed discussion on the treatment<br />
<strong>of</strong> all subtypes is beyond the scope <strong>of</strong> this article,<br />
thus the most common treatment modalities are highlighted<br />
in brief based on the region <strong>of</strong> presentation.<br />
Oropharyngeal lymphoma<br />
The definite management protocol for oropharyngeal<br />
lymphoma has not yet been established. Unlike the majority<br />
<strong>of</strong> other malignancies in this region, surgery does not<br />
play a primary role in the management <strong>of</strong> oropharyngeal<br />
lymphoma [62] . Combined chemotherapy <strong>and</strong> radiotherapy<br />
for localized oropharyngeal lymphoma is recommended<br />
in most studies [14] . Advanced oropharyngeal lymphoma<br />
is usually treated with aggressive chemotherapy with or<br />
without radiotherapy.<br />
Esophageal lymphoma<br />
Due to the rarity <strong>of</strong> esophageal lymphoma, no st<strong>and</strong>ardized<br />
approaches to its management have been formulated.<br />
Secondary lymphoma involving the esophagus can<br />
be treated with chemotherapy, while primary esophageal<br />
lymphoma can be managed with surgery, chemotherapy<br />
<strong>and</strong> radiotherapy or their combination. Treatment protocols<br />
vary depending on its histological subtypes <strong>and</strong><br />
extent. Although surgery is the initial treatment modality,<br />
it has been recently reserved for cases with their diagnosis<br />
not possibly made at endoscopic biopsy or for those who<br />
warrant surgical intervention due to complications such<br />
as perforations. Esophageal lymphoma can be treated<br />
with local resection <strong>and</strong> chemotherapy with or without<br />
radiotherapy as its initial therapy. However, chemotherapy<br />
or radiotherapy alone can be also used as its initial therapy.<br />
The commonly employed chemotherapy regimen is<br />
CHOP in combination with Rituximab. It was reported<br />
that external beam radiation at the dose <strong>of</strong> 40 Gy can<br />
also be used [63] .<br />
Gastric lymphoma<br />
Treatment strategies for gastric lymphoma have changed<br />
dramatically over the last two decades. However, they are<br />
still very controversial. The most widely recommended<br />
702 February 14, 2011|Volume 17|Issue 6|